Comment re: Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: Design issues and implications [1]

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 3, 2007, Pages 464-466

  Hayreh, Sohan Singh ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOLYTIC AGENT;

BLINDNESS; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG FATALITY; ERYTHROCYTE SEDIMENTATION RATE; FIBRINOLYSIS; GIANT CELL ARTERITIS; HEMIPLEGIA; HUMAN; LETTER; NONHUMAN; OPTIC NERVE DISEASE; PHYSICAL DISABILITY; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

FIBRINOLYSIS; FIBRINOLYTIC AGENTS; FLUORESCEIN ANGIOGRAPHY; HEMODILUTION; HUMANS; INFUSIONS, INTRA-ARTERIAL; MULTICENTER STUDIES; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RETINAL ARTERY OCCLUSION; TISSUE PLASMINOGEN ACTIVATOR; VISUAL ACUITY;

EID: 33947147777     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0473-5     Document Type: Letter

References (16)

1. Feltgen N, Neubauer A, Jurklies B, Schmoor C, Schmidt D, Wanke J, Maier-Lenz H, Schumacher M, for the EAGLE-Study Group (2006) Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: Design issues and implications. EAGLE Study report no. 1. Graefes Arch Clin Exp Ophthalmol 244:950-956
2. Hayreh SS (1958) A study of the central artery of the retina in human beings. Thesis for the Master of Surgery. Panjab University (India)
3. Singh (Hayreh) S, Dass R (1960) The central artery of the retina. Br J Ophthalmol 44:193-212, 280-299
4. Hayreh SS, Kolder HE, Weingeist TA (1980) Central retinal artery occlusion and retinal tolerance time. Ophthalmology 87:75-78
5. Hayreh SS, Zimmerman MB, Kimura A, Sanon A (2004) Central retinal artery occlusion. Retinal survival time. Exp Eye Res 78:723-736
6. Hayreh SS, Jonas JB (2000) Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion: An experimental study in rhesus monkeys. Am J Ophthalmol 129:786-795
7. Hayreh SS, Zimmerman B (2005) Central retinal artery occlusion: Visual outcome. Am J Ophthalmol 140:376-391
8. Hayreh SS, Zimmerman B (2006) Fundus changes in central retinal artery occlusion. Retina (In Press)
9. Hayreh SS (2005) Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 24:493-519
10. Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125:509-520
11. Hayreh SS (1999) Retinal arterial occlusion with LIF using rTPA. Ophthalmology 106:1236-1238, 2044
12. Arruga J, Sanders MD (1982) Ophthalmologic findings in 70 patients with evidence of retinal embolism. Ophthalmology 89:1336-1347
13. Richard G, Lerche RC, Knospe V, Zeumer H (1999) Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology 106:768-773
14. The Multicenter Acute Stroke Trial - Europe Study Group (1996) Thrombolytic therapy with streptokinase in acute ischemic stroke. New Eng J Med 335:145-150
15. Donnan GA, Davis SM, Chambers BR, Gatges PC, Hankey GJ, McNeil JJ, Stewart-Wynne EG, Tuck RR, Australian Streptokinase (ASK) Trial Study Group (1996) Streptokinase for acute ischemic stroke with relationship to time of administration. JAMA 276:961-966
16. Barth H, Stein H, Fasse A, Mehdorn HM (1996) Intracerebral hemorrhage after systemic thrombolysis in patients with occlusion of the central retinal artery. Report of 2 cases. Ophthalmologe 93:739-744